Clinical Trial Detail

NCT ID NCT02358863
Title Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach (mEGA)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Georgetown University
Indications

gastroesophageal junction adenocarcinoma

Therapies

Docetaxel + Irinotecan

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Cisplatin + Docetaxel

Cisplatin + Irinotecan

Docetaxel + Epirubicin

Capecitabine + Docetaxel

Age Groups: adult

Additional content available in CKB BOOST